EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax
K Fooks, G Galicia-Vazquez, V Gife… - Journal of Experimental …, 2022 - Springer
Background Acute myeloid leukemia (AML) is an aggressive hematological cancer resulting
from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of …
from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of …
EIF4A inhibition targets bioenergetic homeostasis in AML and synergizes with cytarabine and venetoclax
K Fooks, G Galicia-Vazquez, A Schcolnik-Cabrera… - 2022 - researchsquare.com
Background Acute myeloid leukemia (AML) is an aggressive hematological cancer resulting
from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of …
from uncontrolled proliferation of differentiation-blocked myeloid cells. Seventy percent of …